GlaxoSmithKline reported 20.44B in Loan Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 31129M 1766M
Bayer BAYN:GR € 37918M 4722M
Biogen BIIB:US $ 7269.2M 2M
Bristol Myers Squibb BMY:US $ 42503M 2002M
Eli Lilly And LLY:US $ 16199.6M 387M
Fresenius FRE:GR € 20392M 1851M
Fresenius Medical Care FME:GR € 10336M 347.23M
Galapagos GLPG:NA 22.18M 859K
Genmab GEN:DC 326M 49M
Gilead Sciences GILD:US $ 27907M 738M
Glaxosmithkline GSK:US $ 20442M 2605M
GlaxoSmithKline GSK:LN 20442M 2605M
GRIFOLS GRF:SM € 6730.95M 128.85M
H. Lundbeck A/S LUN:DC 5.75B 61M
Hikma Pharmaceutical HIK:LN 764M 25M
Lonza Group LONN:SW 2.79B 5M
Merck MRK:GR € 9001M 784M
Merk MRK:US $ 24002M 1358M
Novartis NOVN:VX SF 27399M 579M
Orion ORNBV:FH 104.9M 100K
Philips PHIA:NA € 5877M 172M
Recordati REC:IM 800.32M 22.09M
Regeneron Pharmaceuticals REGN:US $ 1978.9M 716.8M